Sunday, January 11, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Truist Securities Analyst Reiterates Hold Recommendation on Best Buy Co

Elaine Mendonca by Elaine Mendonca
March 1, 2024
in Breaking News
0
DVY stock news
0
SHARES
10
VIEWS
Share on FacebookShare on Twitter

Truist Securities analyst Scot Ciccarelli has reiterated a Hold recommendation on Best Buy Co (NYSE: BBY) and increased the price target to $87, indicating his perspective on the company’s potential growth and value. This decision reflects a neutral position on the stock, neither urging investors to buy nor sell shares at this time.

This latest update comes after previous adjustments by Truist Securities, including lowering the price target to $68 from $74 while maintaining a Hold rating. There have also been instances where the price target was decreased to $74 from $80, still with a Hold rating. These changes in price targets mirror shifts in market conditions and analysts’ views on Best Buy’s future performance.

Truist Securities’ consistent Hold recommendation on Best Buy Co, along with revisions in price targets, underscores their continuous monitoring of the company’s progress and market environment. Investors should take this information into account, alongside other factors, when shaping their investment strategies.

Best Buy (BBY) Stock Soars on March 1, 2024: Positive Signs for Investors

On March 1, 2024, Best Buy (BBY) stock showed strong performance, trading near the top of its 52-week range and above its 200-day simple moving average. BBY shares experienced a price increase of $1.20 since the previous market close, representing a 1.51% rise in value. The stock closed at $80.88 on that day.

The fact that BBY was trading near the top of its 52-week range indicates that investors have been bullish on the stock in recent months. Additionally, trading above the 200-day simple moving average is often seen as a bullish signal by technical analysts, suggesting that the stock’s long-term trend is positive.

The $1.20 increase in BBY shares on March 1 demonstrates investor confidence in the company’s prospects. This rise in value could be attributed to positive earnings reports, new product launches, or favorable economic conditions. Whatever the reason, it is clear that investors saw value in BBY stock on that day.

Overall, the strong performance of BBY stock on March 1, 2024, is a positive sign for the company and its investors. With the stock trading near its 52-week high and above its 200-day moving average, it appears that BBY is in a strong position to continue its upward trajectory in the future. Investors will likely be keeping a close eye on the company’s performance in the coming weeks and months to see if it can maintain its positive momentum.

Best Buy Co., Inc. Reports Mixed Financial Results for Past Year, Strong Growth in Last Quarter

Best Buy Co., Inc. (BBY) reported total revenue of $43.45 billion for the past year, a 6.15% decrease compared to the previous year. However, revenue from the last quarter was $14.65 billion, a 50.12% increase. Net income for the past year was $1.24 billion, a 12.54% decrease from the previous year, but net income for the last quarter was $460.00 million, a 74.9% increase. Earnings per share (EPS) for the past year was $5.68, a 9.66% decrease from the previous year, and remained flat at $2.12 from the previous quarter. Best Buy’s performance on March 1, 2024, showed mixed results with declines in total revenue, net income, and EPS compared to the previous year, but improvements from the previous quarter. Investors and analysts will monitor Best Buy’s future financial performances to gauge its growth potential and sustainability in the competitive retail market.

Tags: BBY
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finances (2)

Truist Securities Analyst Maintains Hold Rating on Integra Lifesciences with Revised Price Target

Pharmaceutical Markets and money

Kinnate Biopharma Inc Sells Groundbreaking PanRAF Inhibitor to Pierre Fabre Laboratories for 31 Million

NRx Pharmaceuticals Finalizes Purchase Agreement for Unregistered Shares

Recommended

Transportation Stock Bull Market

JR Kyushu Implements AIPowered AMD Kria K26 SOM for Enhanced Track Inspection Efficiency and Safety

2 years ago
TMUS stock news

Wedbush Analyst Maintains Outperform Rating and Raises Price Target for Global Payments

2 years ago
JD.com Stock

JD.com Shares Surge on Robust Performance and Strategic Moves

3 months ago
Mobile-handsets

Palantir Technologies Reveals Revenue Projections for Q1 2024

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Procter & Gamble Shares Approach a Critical Juncture

Vital Farms Shares Face Headwinds Amid Forecast Revisions and Insider Activity

Palantir Shares: A Wall Street Divide and a Bold New Price Target

Nvidia Accelerates AI Dominance with Early Chip Launch and Strategic Expansions

Netflix Shares Under Pressure Amid High-Stakes Acquisition Battle

Marvell Technology Shares Face Conflicting Market Cues

Trending

Viking Therapeutics Stock
Analysis

Viking Therapeutics: A Tale of Clinical Progress and Insider Selling

by Felix Baarz
January 11, 2026
0

The shares of Viking Therapeutics, a biotechnology firm, are presenting investors with a conflicting narrative this week....

Astera Labs Stock

Astera Labs Shares Face Selling Pressure Amid Strong Fundamentals

January 11, 2026
Realty Income Stock

Institutional Investors Increase Stakes in Realty Income Amid Strategic Refinancing

January 11, 2026
Procter & Gamble Stock

Procter & Gamble Shares Approach a Critical Juncture

January 11, 2026
Vital Farms Stock

Vital Farms Shares Face Headwinds Amid Forecast Revisions and Insider Activity

January 11, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Viking Therapeutics: A Tale of Clinical Progress and Insider Selling
  • Astera Labs Shares Face Selling Pressure Amid Strong Fundamentals
  • Institutional Investors Increase Stakes in Realty Income Amid Strategic Refinancing

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com